FDA Inspection 1303248 - Dendreon Pharmaceuticals LLC - March 25, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Dendreon Pharmaceuticals LLC, with an inspection on March 25, 2026, issued by the Los Angeles District Office, covering biologics.

Company: Dendreon Pharmaceuticals LLC
Inspection Date: March 25, 2026
Product Type: Biologics
Office: Los Angeles District Office

Open in Dashboard

ID · 18d0f24c-cd63-43db-ac7c-9cb2177b0278

Violation Codes9

21 CFR 211.110(a)21 CFR 211.113(b)21 CFR 211.115(b)21 CFR 211.188(b)21 CFR 211.19221 CFR 211.194(a)(8)21 CFR 211.22(d)21 CFR 211.25(a)21 CFR 211.94(a)

Full citation text and observation details available on the Dashboard.